Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Open House Drug Discount Agreements Vildagliptin, Atc A10bh02 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Tobramycin (excl. Hard Capsules With Powder For Inhalation), (obo), Atc J01gb01 F. D. Z. 01.12.2430.11.26 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Guselkumab (exclusively In The Strength 100 Mg), (obo), Atc L04ac16 For The Period 01.12.2024 30.11.2026 2026-10-05
France Conclusion Of Non-exclusive Supply Agreements With The Possibility Of Conclusion At Any Time Within The Framework Of The So-called Open House Procedure 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Tobramycin (excl. Hard Capsules With Powder For Inhalation), (obo), Atc J01gb01 F. D. Z. 01.12.24-30.11.26 2026-10-05
Germany Open House Drug Discount Agreements Rituximab, Atc L01fa01 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Guselkumab (exclusively In The Strength 100 Mg), (obo), Atc L04ac16 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Glatiramer Acetate (prefilled Syringes Only), (obo), Atc L03ax13 For The Period 01.12.2024 30.11.2026 2026-10-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Cladribine (obo), Atc L04aa40 For The Period 01.12.2024 - 30.11.2026 2026-10-05
Germany Open House Drug Discount Agreements Melatonin, Excluding Dosage Form 2 Mg Sustained-release Tablets, Atc N05ch01 2026-10-05
Whats app